IRIS UniCatt

Cenci, Tonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.055
NA - Nord America 2.965
AS - Asia 1.402
SA - Sud America 82
AF - Africa 23
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.536
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.949
DE - Germania 1.347
CN - Cina 797
SE - Svezia 507
SG - Singapore 324
IT - Italia 272
UA - Ucraina 220
FR - Francia 136
IE - Irlanda 133
GB - Regno Unito 122
PL - Polonia 95
ID - Indonesia 77
BR - Brasile 73
FI - Finlandia 72
IN - India 69
RU - Federazione Russa 57
TR - Turchia 50
HK - Hong Kong 21
BE - Belgio 20
NL - Olanda 16
CI - Costa d'Avorio 14
AT - Austria 12
IR - Iran 12
JP - Giappone 12
CA - Canada 9
LT - Lituania 9
VN - Vietnam 9
ES - Italia 8
CH - Svizzera 7
MX - Messico 5
EU - Europa 4
LV - Lettonia 4
RO - Romania 4
AU - Australia 3
BD - Bangladesh 3
EC - Ecuador 3
IL - Israele 3
KR - Corea 3
LK - Sri Lanka 3
MA - Marocco 3
NO - Norvegia 3
ZA - Sudafrica 3
AM - Armenia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.536
Salva come PNG Salva come JPEG
Città #
Ashburn 630
Chandler 513
Hangzhou 313
Singapore 211
Jacksonville 140
Dublin 133
San Mateo 110
Nanjing 104
Nürnberg 98
Beijing 90
Ann Arbor 89
Wilmington 84
Warsaw 82
Jakarta 77
Woodbridge 74
New York 65
Dearborn 64
Houston 64
Fairfield 57
Seattle 51
Cattolica 49
Izmir 48
Los Angeles 47
Nanchang 42
Boston 39
Milan 39
Moscow 38
Lawrence 37
Princeton 33
Rome 32
Bremen 31
Redwood City 31
Kunming 29
Helsinki 28
Munich 27
Hyderabad 25
Redmond 25
Marseille 24
Chicago 23
Lancaster 21
Mountain View 20
Shenyang 20
Hong Kong 18
Brussels 17
Frankfurt am Main 17
Hebei 17
Cambridge 15
Shanghai 15
Abidjan 14
Guangzhou 14
Jiaxing 14
Norwalk 14
Leawood 12
Paris 12
Tianjin 12
Boardman 11
Kraków 11
The Dalles 11
Changsha 10
Düsseldorf 10
Fremont 9
University Park 9
Vienna 9
Zhengzhou 9
Auburn Hills 8
Augusta 7
Berlin 7
Hefei 7
Jinan 7
London 7
Naples 7
North Bergen 7
Pune 7
Stockholm 7
Bedizzole 6
Detroit 6
Edinburgh 6
Nuremberg 6
Portsmouth 6
Verona 6
Dong Ket 5
Gunzenhausen 5
Lanzhou 5
Lauterbourg 5
Simi Valley 5
Bern 4
Changchun 4
Council Bluffs 4
Indiana 4
Ladispoli 4
Mumbai 4
Orange 4
Pomigliano d'Arco 4
Porto Alegre 4
San Diego 4
Santa Clara 4
Washington 4
Andover 3
Falls Church 3
Florence 3
Totale 4.226
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 520
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 453
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 370
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 259
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 212
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 210
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 188
Von hippel-lindau disease and erythrocytosis 159
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 152
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 142
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 139
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 139
PDGFRA-mutant syndrome 137
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 136
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 135
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 132
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 115
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 114
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 110
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 108
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 105
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 104
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 103
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 99
The mutant JAK2 allele burden in children with essential thrombocythemia 94
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 94
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 90
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 88
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 88
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 88
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 86
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 86
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 84
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights 84
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 82
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis 81
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 81
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 81
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 77
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases 74
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 73
Divergent gastrointestinal stromal tumors in syndromic settings 72
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 69
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme 67
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report 67
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 66
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia 65
Methylation study of the Paris system for reporting urinary (TPS) categories 65
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 61
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis 61
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 61
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 60
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 57
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 56
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 56
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 54
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 54
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 53
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 52
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 51
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature 51
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 50
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 49
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 45
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 45
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 43
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 43
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 42
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 41
Telomerase inhibition in malignant gliomas. A systematic review 40
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 39
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)) 36
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 34
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 33
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 33
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 32
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 28
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 28
Totale 7.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 0 0 0 0 0 0 117 79
2020/2021642 48 101 53 56 76 43 53 7 74 26 91 14
2021/2022679 73 44 18 65 58 20 16 97 28 48 90 122
2022/20231.388 203 205 105 217 93 164 56 87 162 28 48 20
2023/20241.129 27 210 25 50 16 95 265 261 6 30 68 76
2024/2025829 34 30 124 42 108 51 44 55 183 148 10 0
Totale 7.631